|
|||||
|
|
Randomized, Double-Masked, Sham-Controlled Trial of Ranibizumab for Neovascular Age-Related Macular Degeneration: PIER Study Year 2 |
|
| Authors: | Prema Abraham [Author Vitae] Huibin Yue |
| Affiliation: | a Black Hills Regional Eye Institute, Rapid City, South Dakota b Genentech, Inc, South San Francisco, California |
| Abstract: | |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ | |